Skip to main content

Table 1 Patient sample characteristics (n = 314) for 3 MOA groups

From: Effects of mode of administration (MOA) on the measurement properties of the EORTC QLQ-C30: a randomized study

Individual Characteristics

Paper & pencil at home

(n = 132)

Telephone

(n = 121)

Paper & pencil in-clinic

(n = 61)

 
 

Means (s.d.)

Means (s.d.)

Means (s.d.)

Sig.

Age

56.6(12.9)

57.0(12.0)

54.1(11.5)

.30

KPS

77.4(14.4)

78.1(13.7)

78.0(15.0)

.93

 

N(%)

N(%)

N(%)

 

Sex (%)

    

   Male

48(36%)

47(39%)

16(27%)

.23

Marital Status

    

   Single

11(8%)

9(8%)

6(10%)

.92

   Married

99(75%)

97(81%)

44(73%)

 

Divorced

10(8%)

7(6%)

5(8%)

 

   Widowed

12(9%)

7(6%)

5(8%)

 

Education

    

   <10 years

70(53%)

69(58%)

32(53%)

.21

   10-15 years

39(30%)

35(29%)

12(20%)

 

   >15 years

23(17%)

16(13%)

16(27%)

 

Employed

    

   Yes

50(38%)

41(35%)

19(32%)

.70

Stage of Disease*

    

   Local/regional

86(66%)

73(61%)

28(47%)

.04

Treatment**

    

   Chemotherapy

56(42%)

50(41%)

44(73%)

<.00

   Radiotherapy

70(53%)

67(55%)

15(25%)

 

   RT+CT/other

6(5%)

4(3%)

1(2%)

 

Comorbidity

    

   Yes

74%

74%

69%

.76

Primary Site

    

   Breast

48(36%)

49(41%)

32(53%)

.11

   Colorectal

38(29%)

31(26%)

10(17%)

 

   Lung

36(27%)

29(24%)

9(15%)

 

   Other

10(8%)

12(10%)

9(15%)

 
  1. * p < 0.05 ** p < 0.01